Essential nutrients and cerebral small vessel diseases: a two-sample Mendelian randomization study
- PMID: 37426181
- PMCID: PMC10325681
- DOI: 10.3389/fnut.2023.1172587
Essential nutrients and cerebral small vessel diseases: a two-sample Mendelian randomization study
Abstract
Background: Previous studies have suggested a potential association between nutrients and cerebral small vessel disease (CSVD), but this association has not been fully addressed.
Object: We intended to clarify the causal associations between four categories of essential nutrients (amino acids, polyunsaturated fatty acids, minerals and vitamins) and two acute manifestations of CSVD (intracerebral hemorrhage and small vessel stroke) using two-sample Mendelian randomization (MR) analysis.
Method: We obtained European-based large-scale genome-wide association studies (GWASs) related to CSVD (6,255 cases and 233,058 controls) and nutrient concentrations. Causality evaluation mainly included the results of the inverse variance-weighted (IVW) method. The simple median method, the weighted median method and the MR-Egger method were adopted for sensitivity analyses.
Results: For ICH or SVS, increased levels of phenylalanine (OR = 1.188, p < 0.001) and dihomo-gamma-linolenic acid (DGLA) (OR = 1.153, p = 0.001) showed risk effects, while docosapentaenoic acid (DPA) (OR = 0.501, p < 0.001), zinc (OR = 0.919, p < 0.001), and arachidonic acid (OR = 0.966, p = 0.007) showed protective effects. For lobar hemorrhage or SVS, AA (OR = 0.978, p < 0.001), zinc (OR = 0.918, p < 0.001), and retinol (OR = 0.753, p < 0.001) showed risk effects; DPA (OR = 0.682, p = 0.022), gamma-linolenic acid (OR = 0.120, p = 0.033) and 25(OH)D (OR = 0.874, p = 0.040) showed protective effects. For nonlobar hemorrhage or SVS, DGLA (OR = 1.088, p < 0.001) and phenylalanine (OR = 1.175, p = 0.001) showed risk effects.
Conclusion: Our study analyzed the effect of nutrients on CSVD risk from a genetic perspective, with implications for CSVD prevention through nutrient supplementation.
Keywords: Mendelian randomization; cerebral small vessel disease; intracerebral hemorrhage; nutrient; small vessel stroke.
Copyright © 2023 Li, Xia, Wang, Liu, Tong, Wang, Zhou, Zhang, Tang, Fan and Yang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Women's reproductive traits and cerebral small-vessel disease: A two-sample Mendelian randomization study.Front Neurol. 2023 Mar 30;14:1064081. doi: 10.3389/fneur.2023.1064081. eCollection 2023. Front Neurol. 2023. PMID: 37064189 Free PMC article.
-
Cerebral small vessel disease increases risk for epilepsy: a Mendelian randomization study.Neurol Sci. 2024 May;45(5):2171-2180. doi: 10.1007/s10072-023-07221-w. Epub 2023 Nov 28. Neurol Sci. 2024. PMID: 38012465
-
Associations between polyunsaturated fatty acid concentrations and Parkinson's disease: A two-sample Mendelian randomization study.Front Aging Neurosci. 2023 Feb 22;15:1123239. doi: 10.3389/fnagi.2023.1123239. eCollection 2023. Front Aging Neurosci. 2023. PMID: 36909950 Free PMC article.
-
Dietary-Derived Essential Nutrients and Amyotrophic Lateral Sclerosis: A Two-Sample Mendelian Randomization Study.Nutrients. 2022 Feb 22;14(5):920. doi: 10.3390/nu14050920. Nutrients. 2022. PMID: 35267896 Free PMC article.
-
Causal Effect of the 25-Hydroxyvitamin D Concentration on Cerebral Small Vessel Disease: A Mendelian Randomization Study.Stroke. 2023 Sep;54(9):2338-2346. doi: 10.1161/STROKEAHA.123.042980. Epub 2023 Jul 19. Stroke. 2023. PMID: 37465996 Free PMC article.
Cited by
-
The plasma lipids with different fatty acid chains are associated with the risk of hemorrhagic stroke: a Mendelian randomization study.Front Neurol. 2024 Jul 30;15:1432878. doi: 10.3389/fneur.2024.1432878. eCollection 2024. Front Neurol. 2024. PMID: 39139767 Free PMC article.
References
LinkOut - more resources
Full Text Sources